This is a repost...for some reason the messages isn't getting through...
It simply amazes me how many fludarabine treated CLL patients are not aware of this fact... it also apples to Cladrabine and pentostatin all purine analogs in fact. Also a good idea for bendamustine and campath...
'Patients treated with purine analogue drugs (fludarabine, cladribine and deoxycoformicin) should receive irradiated blood components indefinitely (1B). The situation with other purine antagonists and new and related agents, such as bendamustine and clofarabine, is unclear, but use of irradiated blood components is recommended as these agents have a similar mode of action. Irradiated blood components should be used after alemtuzumab (anti-CD52) therapy. Their use after rituximab (anti-CD20) is not recommended at this time. As new potent immunosupressive drugs and biological agents are introduced into practice there is a need for regular review of these recommendations (2C).'
hospital.blood.co.uk/librar...